TCM
NEPH icon

Topline Capital Management’s Nephros NEPH Stock Holding History

Topline Capital Management’s Portfolio NEPH Stock Details NEPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.73M Sell
581,967
-32,335
-5% -$129K 0.29% 31
2025
Q4 		$3M Buy
614,302
+18,002
+3% +$92K 0.27% 35
2025
Q3 		$2.82M Buy
596,300
+118,851
+25% +$467K 0.48% 28
2025
Q2 		$1.95M Buy
477,449
+55,360
+13% +$148K 0.33% 30
2025
Q1 		$726K Buy
422,089
+2,202
+0.5% +$3.45K 0.17% 34
2024
Q4 		$617K Buy
+419,887
New +$640K 0.12% 33

Other funds holding NEPH

WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Cornerstone Capital Palo Alto, California $1.12B AUM 28.84% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Topline Capital Management's NEPH Position: Q1 2026 in Review

Topline Capital Management reduced its Nephros (NEPH) stake by 5.3% in Q1 2026, selling an estimated $129K and leaving 581,967 shares worth $1.73M. The position accounts for 0.29% of the portfolio, ranked #31.

Topline Capital Management first reported a position in NEPH in Q4 2024 and has held it in 6 quarters since. The position peaked at $3M in Q4 2025. 27 funds tracked by Wall St. Rank hold NEPH as of Q1 2026.

  • Topline Capital Management held 581,967 shares of Nephros worth $1.73M as of Q1 2026.
  • Topline Capital Management sold 32,335 Nephros shares in Q1 2026, an estimated $129K.
  • Nephros made up 0.29% of Topline Capital Management's portfolio in Q1 2026, its #31 holding.
  • Topline Capital Management first reported a position in Nephros in Q4 2024 and has held it in 6 quarters since.
  • Topline Capital Management's Nephros position peaked at $3M in Q4 2025.
  • 27 funds tracked by Wall St. Rank held Nephros as of Q1 2026.

Based on Topline Capital Management's 13F filing for Q1 2026, filed 15 May 2026.